You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 124 No. 9, September 1988 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  STUDIES
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (62)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Cutaneous Hypoxia in Patients With Systemic Sclerosis (Scleroderma)

Judith L. Silverstein, MD; Virginia D. Steen, MD; Thomas A. Medsger, Jr, MD; Vincent Falanga, MD

Arch Dermatol. 1988;124(9):1379-1382.


Abstract



• Measurement of transcutaneous oxygen pressure (Tcpo2) is an established and noninvasive way of assessing cutaneous hypoxia. Since the degree of oxygénation modulates fibroblast growth and synthesis, we investigated the presence of cutaneous hypoxia in patients with systemic sclerosis (SS). We measured Tcpo2 of the involved skin of the dorsal aspect of the forearm in 33 patients with SS and 16 control individuals (normal subjects and patients with Raynaud's disease). The degree of forearm skin thickness was assessed clinically as mild, moderate, or severe. The Tcpo2 measurements were obtained at a sensor temperature of 44°C, which causes maximal vasodilation and eliminates the variables associated with vascular tone. Measurements were recorded while patients were breathing room air or 31% oxygen delivered by a Ventimask system (Baxter Healthcare, Ocala, Fla). We also measured the Tcpo2 of the medial aspect of the arm when this site was uninvolved. We found that sclerodermatous skin is hypoxic when compared with the uninvolved skin of patients with SS or control individuals. The Tcpo2 values were indirectly related to skin thickness; thus, patients whose skin was severely thickened had the lowest Tcpo2 values. There was no correlation of Tcpo2 values with pulmonary function tests or arterial oxygen pressure. The Tcpo2 levels of patients with Raynaud's disease did not differ from other control individuals. The administration of oxygen increased Tcpo2 readings in patients with SS to normal values. We conclude that the thickened skin of patients with SS is hypoxic and suggest that Tcpo2 measurements may be helpful in objectively assessing the degree of skin thickness. The hypoxia demonstrated in SS skin may play a role in the modulation of dermal fibroblast proliferation and synthetic activity.

(Arch Dermatol 1988;128:1379-1382)



Author Affiliations



From the Department of Dermatology and Cutaneous Surgery, University of Miami School of Medicine (Dr Falanga) and the Departments of Dermatology (Dr Silverstein) and Medicine (Drs Steen and Medsger), University of Pittsburgh School of Medicine.


Footnotes



Accepted for publication April 5, 1988.

Reprint requests to Department of Dermatology and Cutaneous Surgery, University of Miami School of Medicine, PO Box 016250 (R-250), Miami, FL 33101 (Dr Falanga).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Testing for Hypoxia in Forearm Skin of Patients with Systemic Sclerosis, Assessed by Pimonidazole
HERRICK et al.
The Journal of Rheumatology 2010;37:1968-1969.
FULL TEXT  

Cardiopulmonary Exercise Testing with Right-heart Catheterization in Patients with Systemic Sclerosis
WALKEY et al.
The Journal of Rheumatology 2010;37:1871-1877.
ABSTRACT | FULL TEXT  

Transforming Growth Factor-beta Receptor Type I-dependent Fibrogenic Gene Program Is Mediated via Activation of Smad1 and ERK1/2 Pathways
Pannu et al.
J. Biol. Chem. 2007;282:10405-10413.
ABSTRACT | FULL TEXT  

Hypoxia and Transforming Growth Factor-{beta}1 Act Independently to Increase Extracellular Matrix Production by Placental Fibroblasts
Chen et al.
J. Clin. Endocrinol. Metab. 2005;90:1083-1090.
ABSTRACT | FULL TEXT  

Regulation of endothelial heme oxygenase activity during hypoxia is dependent on chelatable iron
Ryter et al.
Am. J. Physiol. Heart Circ. Physiol. 2000;279:H2889-H2897.
ABSTRACT | FULL TEXT  

Induction of heme oxygenase-1 by hypoxia and free radicals in human dermal fibroblasts
Panchenko et al.
Am. J. Physiol. Cell Physiol. 2000;278:C92-C101.
ABSTRACT | FULL TEXT  

Egr-1 Mediates Transcriptional Activation of IGF-II Gene in Response to Hypoxia
Bae et al.
Cancer Res. 1999;59:5989-5994.
ABSTRACT | FULL TEXT  

Hypoxia downregulates tropoelastin gene expression in rat lung fibroblasts by pretranslational mechanisms
Berk et al.
Am. J. Physiol. Lung Cell. Mol. Physiol. 1999;277:L566-L572.
ABSTRACT | FULL TEXT  

Hypoxia-inducible Factor-1 Mediates Transcriptional Activation of the Heme Oxygenase-1 Gene in Response to Hypoxia
Lee et al.
J. Biol. Chem. 1997;272:5375-5381.
ABSTRACT | FULL TEXT  

Transcutaneous Oxygen and Carbon Dioxide Measurement in Peripheral Vascular Disease
Melillo et al.
VASC ENDOVASCULAR SURG 1995;29:273-280.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1988 American Medical Association. All Rights Reserved.